These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2425540)

  • 21. Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.
    Bartoloni C; Guidi L; Scoppetta C; Tonali P; Bartoccioni E; Flamini G; Gambassi G; Terranova T
    J Neurol Neurosurg Psychiatry; 1981 Oct; 44(10):901-5. PubMed ID: 7310408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of immune complexes in the sera and around the muscle fibers in a case of myasthenia gravis and polymyositis].
    Shimada K; Koh CS; Tsukada N; Shoji S; Yanagisawa N
    Rinsho Shinkeigaku; 1989 Apr; 29(4):432-5. PubMed ID: 2533018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thymic tumors and associated syndromes].
    Zoupanos G
    Rev Med Suisse Romande; 1971 Feb; 91(2):99-121. PubMed ID: 5579013
    [No Abstract]   [Full Text] [Related]  

  • 26. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis associated with carcinoma of the thymus. A report of three cases].
    Viéitez MC; Aladró Y; Alemany MJ; Amela R; Muñoz C; Santana N
    Rev Neurol; 2001 Jun 16-30; 32(12):1135-7. PubMed ID: 11562844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of malignant thymoma associated with myasthenia gravis, pure red cell aplasia and high serum level of SCC antigen].
    Hanawa T; Matsubara Y; Sawai S; Ishida H; Matsui T; Chiba W; Kosaba S; Watanabe S; Hatanaka R; Funazu T
    Kyobu Geka; 1993 Jan; 46(1):69-73. PubMed ID: 8418363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens.
    Gilhus NE; Aarli JA; Matre R
    J Neuroimmunol; 1983 Dec; 5(3):239-49. PubMed ID: 6361067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative antistriate muscle antibody titers in malignant thymoma associated with myasthenia gravis: case report.
    Watters MR
    Mil Med; 1983 Feb; 148(2):145-7. PubMed ID: 6405314
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies to skeletal muscle in myasthenia gravis. Part 3. Relation with clinical course and therapy.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(2):168-73. PubMed ID: 8138806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myasthenia gravis and thymoma].
    Gundersen B; Gilhus NE; Aarli JA
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1207-8. PubMed ID: 2333645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty.
    Lanska DJ
    Neurology; 1991 Apr; 41(4):520-4. PubMed ID: 2011250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database.
    Nakajima J; Okumura M; Yano M; Date H; Onuki T; Haniuda M; Sano Y;
    Eur J Cardiothorac Surg; 2016 May; 49(5):1510-5. PubMed ID: 26537756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
    Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y; Yu L; Jing Y; Ke J
    Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
    Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
    Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(1):78-81. PubMed ID: 8289082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.